Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 6/2013

01-06-2013 | Letter to the Editor

Molecular basis of primary iron overload in India and the role of serum-derived factors in hepcidin regulation

Authors: Rekha Athiyarath, Alok Srivastava, Eunice Sindhuvi Edison

Published in: Annals of Hematology | Issue 6/2013

Login to get access

Excerpt

Dear Editor, …
Appendix
Available only for authorised users
Literature
1.
Thakur V et al (2004) Absence of hemochromatosis associated Cys282Tyr HFE gene mutation and low frequency of hemochromatosis phenotype in non-alcoholic chronic liver disease patients in India. J Gastroenterol Hepatol 19(1):86–90PubMedCrossRef
2.
Dhillon BK et al (2007) Frequency of primary iron overload and HFE gene mutations (C282Y, H63D and S65C) in chronic liver disease patients in north India. World J Gastroenterol 13(21):2956–2959PubMed
3.
Aguilar-Martinez P et al (1999) Haplotype analysis of the HFE gene: implications for the origins of hemochromatosis related mutations. Blood Cells Mol Dis 25(3–4):166–169PubMedCrossRef
4.
Beutler E, West C (1997) New diallelic markers in the HLA region of chromosome 6. Blood Cells Mol Dis 23(2):219–229PubMedCrossRef
5.
Dhillon BK et al (2012) H63D mutation in HFE gene is common in Indians and is associated with the European haplotype. J Genet 91(2):229–232PubMedCrossRef
6.
Ravasi G et al (2012) Hepcidin expression in iron overload diseases is variably modulated by circulating factors. PLoS One 7(5):e36425PubMedCrossRef
7.
Ramos P et al (2010) Enhanced erythropoiesis in Hfe-KO mice indicates a role for Hfe in the modulation of erythroid iron homeostasis. Blood 117(4):1379–1389PubMedCrossRef
8.
Jain S et al (2011) Lack of association of primary iron overload and common HFE gene mutations with liver cirrhosis in adult Indian population. Indian J Gastroenterol 30(4):161–165PubMedCrossRef
9.
Shukla P et al (2006) HFE, hepcidin and ferroportin gene mutations are not present in Indian patients with primary haemochromatosis. Natl Med J India 19(1):20–23PubMed
Metadata
Title
Molecular basis of primary iron overload in India and the role of serum-derived factors in hepcidin regulation
Authors
Rekha Athiyarath
Alok Srivastava
Eunice Sindhuvi Edison
Publication date
01-06-2013
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 6/2013
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-012-1621-0

Other articles of this Issue 6/2013

Annals of Hematology 6/2013 Go to the issue

Original Article

A retrospective analysis of primary gastric diffuse large B-cell lymphoma with or without concomitant mucosa-associated lymphoid tissue (MALT) lymphoma components

Letter to the Editor

Pericardial effusion due to pericardium involvement by Hodgkin’s lymphoma

Original Article

Hepatitis C in patients with β-thalassemia major. A single-centre experience

Original Article

Acute leukemias of ambiguous lineage in adults: molecular and clinical characterization

Original Article

The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study

Original Article

Prevalence and incidence of anemia in the German Heinz Nixdorf Recall Study
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits